Resurgent Financial Advisors LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1912339
ATLANTA, GA
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$562,640
+$41,730 QoQ
Shares Held
1,260
+9.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Resurgent Financial Advisors LLC holds $166,618 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RXRX |
Recursion Pharmaceuticals, Inc.
|
45,400 | $166,618 |
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $562,640 | 1,260 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $520,910 | 1,149 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $270,236 | 607 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $291,376 | 601 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $235,982 | 586 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $409,270 | 880 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $421,379 | 899 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $417,591 | 999 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $329,580 | 810 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $82,066 | 236 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $77,068 | 219 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $71,205 | 226 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $201,857 | 699 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $385,956 | 1,333 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $355,337 | 1,261 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $348,916 | 1,337 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||